Latest news for Green Impact Partners (OTC:GIPIF) Stock

Green Impact Partners Inc is a clean energy company with an operating portfolio of water and solids treatment and recycling facilities in North America. The company also has a portfolio of renewable natural gas and clean energy development projects. Its services include water and solids recycling management, disposal services, and energy product optimization services. Its operating segments are Water & Solids Recycling & Energy Product Optimization and Clean Energy Production. Its core focus is that GIP has an infrastructure network located throughout western Canada and the United States that includes wastewater, hydrocarbon processing, disposal facilities, industrial landfill, recycling facilities, oil and water gathering pipelines, and oil terminals.

GREEN IMPACT PARTNERS INC by GREEN IMPACT PARTNERS INC

Green Impact Partners Inc

Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) ("Xiao-I" or the "Company"), a leading artificial intelligence company, today announced the renewal of its contract with Inner Mongolia Yili Industrial Group Co., Ltd. ("Yili") (A Share:600887). This renewal continues a long-standing partnership and marks an important shift, as Yili transitions its AI-driven customer service platform to a subscription-based model, optimizing service delivery and increasing operational efficiency. This transition to a subscription model, known as Maas (Model as a Service), represents a new business model that Xiao-I has been actively promoting. It reflects a broader trend in the software and AI industries, offering greater flexibility and scalability for clients like Yili. The shift is also expected to contribute to Xiao-I's long-term financial stability by creating stronger customer retention and improving cash flow predictability.

News

Global

AIXI

Xiao-I Corp Renews And Expands Partnership With Inner Mongolia Yili, Transitioning To Subscription-Based Model For AI Services, Optimizing Service Delivery And Increasing Operational Efficiency

RBC Capital analyst Rishi Jaluria reiterates Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Outperform and maintains $300 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Salesforce, Maintains $300 Price Target

Flex's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NYSE">FLEX</a>) short percent of float has fallen 4.38% since its last report. The company recently reported that it has 6.41 million shares sold short, which is 2.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.55 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Flex Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726753523_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Flex has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Flex's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Flex's peer group average for short interest as a percentage of float is 2.90%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

FLEX

How Is The Market Feeling About Flex?

Salesforce's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) short percent of float has fallen 13.42% since its last report. The company recently reported that it has 11.97 million shares sold short, which is 1.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Salesforce Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726753518_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Salesforce has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Salesforce's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Salesforce's peer group average for short interest as a percentage of float is 3.35%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Salesforce's Recent Short Interest

Tonix Pharmaceuticals's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NYSE">TNXP</a>) short percent of float has risen 122.12% since its last report. The company recently reported that it has 1.57 million shares sold short, which is 7.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Tonix Pharmaceuticals Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726753512_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tonix Pharmaceuticals has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Tonix Pharmaceuticals's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Tonix Pharmaceuticals's peer group average for short interest as a percentage of float is 5.53%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TNXP

Looking Into Tonix Pharmaceuticals's Recent Short Interest

U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 400 points on Thursday.
Following the market opening Thursday, the Dow traded up 1.44% to 42,100.00 while the NASDAQ rose 2.30% to 17,976.85. The S&amp;P 500 also rose, gaining, 1.65% to 5,710.85.
Check This Out: <a href="https://www.benzinga.com/news/24/09/40937584/alphabet-mcdonalds-and-2-other-stocks-executives-are-selling">Alphabet, McDonald&#8217;s And 2 Other Stocks Executives Are Selling</a>
Leading and Lagging Sectors Information technology shares jumped by 2.7% on Thursday.
In trading on Thursday, utilities shares fell by 0.1%.
Top Headline
U.S. initial jobless claims fell by 12,000 from the prior week to 219,000 in the week ending September 14, compared to market expectations of 230,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 245% to $4.67. Telesis Bio recently announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Shares of Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) got a boost, surging 185% to $0.3702 after the company announced it will acquire sports gaming technology company Swifty Global.</li>
<li>Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares were also up, gaining 153% to $2.96 after declining around 9% on Wednesday.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Haoxi Health Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares dropped 74% to $0.77. Haoxi Health Technology announced the pricing of a $12 million underwritten follow-on public offering of 4 million units at a price of $3/unit.</li>
<li>Shares of Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) were down 39% to $14.96 after a client elected to exercise an option to terminate its services agreement with the company.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) was down, falling 23% to $3.19 after the company announced a $4.3 million registered offering of 1.36 million shares of common stock at $3.15 per share.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $71.71 while gold traded up 0.2% at $2,602.70.
Silver traded up 2.2% to $31.355 on Thursday, while copper rose 1.7% to $4.3720.
Euro zone
European shares were higher today. The eurozone's STOXX 600 climbed 1.4%, Germany's DAX climbed 1.6% and France's CAC 40 jumped 2%. Spain's IBEX 35 Index rose 0.7%, while London's FTSE 100 rose 1%.
The Bank of England maintained the Bank Rate at 5% during its September meeting, after cutting rates by 25 bps in August. The current account surplus in the Eurozone increased to €48 billion in July from €25.5 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Thursday, with Japan's Nikkei 225 gaining 2.13%, Hong Kong's Hang Seng Index surging 2%, China's Shanghai Composite Index gaining 0.69% and India's BSE Sensex gaining 0.29%.
Hong Kong's unemployment rate came in unchanged at 3% in the three months ending August. The Hong Kong Monetary Authority cut its base rate by 50bps to 5.25% at its recent meeting.
Economics
<ul>
<li>The U.S. reported a current account deficit of $266.8 billion in the second quarter versus a gap of $241 billion in the prior period and higher than market estimates of a $260 billion gap.</li>
<li>U.S. initial jobless claims fell by 12,000 from the prior week to 219,000 in the week ending September 14, compared to market expectations of 230,000.</li>
<li>The Philadelphia Fed Manufacturing Index climbed to 1.7 in September from -7 in the previous month and topping market estimates of -1.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40937617/top-3-defensive-stocks-you-may-want-to-dump-in-september">Top 3 Defensive Stocks You May Want To Dump In September</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

Markets

PGNY

TBIO

VVOS

Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000

Wells Fargo analyst Steven Cahall downgrades Boston Omaha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOC#NYSE">BOC</a>) from Overweight to Equal-Weight and lowers the price target from $17 to $15.

Downgrades

Wells Fargo Downgrades Boston Omaha to Equal-Weight, Lowers Price Target to $15

Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares are making new 52-week highs Thursday morning. Here&#8217;s a look at <a href="https://www.benzinga.com/markets/equities/24/09/40931562/cathie-woods-ark-invest-continues-dumping-robinhood-and-palantir-shares-as-interest-rates-fall">what&#8217;s going on</a>.
What Happened: Palantir shares are on watch Thursday after the company was awarded a new $99.8 million contract by the United States Army.
According to a <a href="https://www.defense.gov/News/Contracts/Contract/Article/3910169/">contract update</a> posted on the U.S. Department of Defense&#8217;s (DOD) website, Palantir has been awarded a $99.804 million firm-fixed-price contract that involves user licenses for the Maven Smart System AI tool, ancillary software support and hardware.
The DOD release states that the contract has an estimated completion date of Sept. 24, 2029.&nbsp;Work locations and funding will be determined with each order.
Palantir was previously awarded a <a href="https://www.benzinga.com/markets/equities/24/05/39079527/palantir-stock-shrugs-off-cramers-sell-call-as-480m-ai-contract-for-army-fuels-premarket-rally">$480 million firm-fixed-price contract</a> by the U.S. Army for the&nbsp;Maven Smart System&nbsp;prototype in May. That contract has an estimated completion date of May 28, 2029.
Palantir&#8217;s <a href="https://www.benzinga.com/news/earnings/24/08/40172453/palantir-q2-earnings-revenue-beat-eps-beat-customer-count-up-41-driven-by-strength-in-us-commercial#">latest quarterly results</a> showed that U.S. government revenue grew 24% year-over-year in the second quarter to $278 million. Total government revenue was up 23% year-over-year to $371 million.
Palantir is not due to report earnings again until sometime around the end of October. Analysts are currently forecasting earnings of 9 cents per share and revenue of $701.13 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Palantir shares are also benefiting from strength across broader markets on the heels of a 0.5% rate cut from the Federal Reserve on Wednesday. This week&#8217;s 0.5% rate cut brought the&nbsp;target fed funds rate&nbsp;to a new range&nbsp;between 4.75% and 5%, down from a 23-year high of 5.25% to 5.5%. It was also the first rate cut since March 2020.
See Also: <a href="https://www.benzinga.com/markets/equities/24/09/40931562/cathie-woods-ark-invest-continues-dumping-robinhood-and-palantir-shares-as-interest-rates-fall#google_vignette">Cathie Wood&#8217;s Ark Invest Continues Dumping Robinhood And Palantir Shares As Interest Rates Fall</a>
PLTR Price Action: Palantir shares were down 0.4% at $36.24 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Contracts

Movers

PLTR

Palantir Stock Hits 52-Week Highs Thursday: What's Going On?

RBC Capital analyst Nik Modi reiterates General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Sector Perform and maintains $70 price target.

RBC Capital Reiterates Sector Perform on General Mills, Maintains $70 Price Target

WIIM

UROY

UUUU

Shares of uranium stocks are trading higher, possibly as the US investigates if China is helping Russia circumnavigate the commodity's ban. Also, Russian President Putin last week reportedly considered restrictions on uranium exports.

RBC Capital analyst Rishi Jaluria reiterates HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) with a Outperform and maintains $700 price target.

HUBS

RBC Capital Reiterates Outperform on HubSpot, Maintains $700 Price Target

<a href="https://www.defense.gov/News/Contracts/Contract/Article/3910169/" title="https://www.defense.gov/News/Contracts/Contract/Article/3910169/">https://www.defense.gov/News/Contracts/Contract/Article/3910169/</a>

GNTX

Reported September 18; Gentex Awarded $8.1M Contract Modification For HGU-56/P Aircrew Helmet System And Components, With Completion Expected By September 2025

Reported September 18; Teledyne FLIR Awarded $13.2M Contract Modification For IdentiFINDER Systems And Support, With Work To Be Completed By September 2027

FibroBiologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBLG#NASDAQ">FBLG</a>) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it has engaged with Southern Star Research to provide clinical research organization (CRO) services for FibroBiologics in Australia. Initial CRO services will include preparatory work for a Phase 1/2 clinical trial utilizing product candidate, CYWC628, to treat diabetic foot ulcers.

Biotech

General

FBLG

FibroBiologics Engages Southern Star Research As Clinical Research Organization In Australia, Initial CRO Services Will Include Preparatory Work For A Phase 1/2 Clinical Trial Utilizing Product Candidate, CYWC628, To Treat Diabetic Foot Ulcers

Reported September 18; Northrop Grumman Awarded $17.9M Contract For Inertial Measuring Units For WSN-7 Weapon System, Work To Be Completed By June 2030

Reported September 18; Boeing Awarded $29.5M Contract For F/A-18 E/F Black III Windshield Panel Spares, Work To Be Completed By December 2029

Reported September 18; Raytheon Awarded $18.6M Contract For International Field Artillery Tactical Data Systems, With Completion Expected By September 2026, Funded By 2024 Foreign Military Sales To Georgia

Reported September 18; Palantir USG Awarded $99.8M Contract For Maven Smart System AI Tool, Software Support, And Hardware, With Completion Expected By September 2029

T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) shares are trading higher today. The company disclosed long-term <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925481/fueled-by-network-leadership-and-transformative-ai-enabled-customer-experiences-t-mobile-outlines-" rel="noreferrer noopener">goals, AI deals, and a dividend hike on Wednesday.</a>
T-Mobile revealed a three-year plan to drive growth. The strategy comprises expanding its AI-driven, digital-first approach, increasing market share in underpenetrated areas, boosting broadband growth, and exploring new revenue streams.
The company exceeded its 2021 Capital Markets Day goals, including building a solid network in America, expanding market reach, and achieving $8 billion in synergies from the Sprint merger.
Apart from this, T-Mobile plans to enhance its network leadership with advanced technologies like Massive MIMO, VoNR, and 5G Advanced, backed by its nationwide 5G standalone network.
In a separate release, T-Mobile and OpenAI disclosed a transformative multi-year partnership aimed at revolutionizing customer experience. This collaboration merges T-Mobile&#8217;s deep customer relationship skills with OpenAI&#8217;s cutting-edge <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40922898/t-mobile-and-openai-join-forces-to-revolutionize-the-customer-experience-with-first-ever-intent-dr" rel="noreferrer noopener">AI technology and R&amp;D capabilities</a>.
T-Mobile CEO Mike Sievert said, &#8220;T-Mobile is a company on the move with tremendous opportunities in front of us to further extend our outperformance in customer growth and translate that into strong top and bottom-line growth that will enable a compelling capital return opportunity over the next few years,&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40925493/t-mobile-partners-with-nvidia-ericsson-and-nokia-to-pioneer-ai-driven-mobile-networks" rel="noreferrer noopener">T-Mobile Partners with NVIDIA, Ericsson, And Nokia to Pioneer AI-Driven Mobile Networks</a>
Outlook: T-Mobile expects service revenue between $75 billion and $76 billion and adjusted free cash flow of<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> $18 billion-$19 billion in 2027</a>.
T-Mobile for Business (TFB) is anticipated to deliver double-digit growth, with overall service revenue projected to grow at a 5% CAGR from 2023 to 2027.
The company now targets 12 million 5G broadband customers by 2028, significantly raising its previous goal of 7 to 8 million by 2025.
The company projects core Adjusted EBITDA growth, targeting $38 billion&nbsp;to $39 billion in 2027, reflecting a 7% CAGR at the midpoint from 2023 and a $10 billion increase from 2023 at the high end of&nbsp;guidance.
This growth is expected to be fueled by operational leverage and efficiencies from technology, AI, and digital innovation.
Dividend Boost: T-Mobile disclosed that its Board of Directors has declared a cash dividend of $0.88 per share, reflecting a 35% increase from the previous quarter.
The dividend will be payable on December 12, 2024, to stockholders of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925518/t-mobile-announces-a-35-quarterly-dividend-increase" rel="noreferrer noopener">record as of November 27, 2024</a>.
Also, the company plans to allocate around $80 billion through 2027 for investments and shareholder returns, including up to $50 billion for dividends and share repurchases (in addition to the $25 billion already returned to shareholders).
Apart from this, T-Mobile introduced T-Priority, the world&#8217;s first 5G network slice dedicated to first responders, providing advanced connectivity solutions and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925495/t-mobile-introduces-t-priority-featuring-the-worlds-first-network-slice-for-first-responders" rel="noreferrer noopener">unparalleled support for emergency situations</a>.
Investors can focus on the stock via&nbsp;The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)and&nbsp;Invesco BuyBack Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKW#NASDAQ">PKW</a>).
Price Action: TMUS shares are up 1.04% at $198.73 at the last check Thursday.
Photo by viewimage on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40932937/apple-iphone-16-selling-at-a-greater-rate-than-last-year-says-t-mobile-ceo-amid-reports-of-lower" target="_blank" rel="noreferrer noopener">Apple iPhone 16 Selling At A &#8216;Greater Rate Than Last Year,&#8217; Says T-Mobile CEO Amid Reports Of Lower Demand: &#8216;People Are Buying Pros, They&#8217;re Buying Maxs… They&#8217;re Buying Up The Food Chain&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Large Cap

Guidance

TMUS

T-Mobile Surpasses 2021 Capital Markets Day Goals, Sets New Ambitions, Boosts Dividend & More

Clinical Advisory Board to Provide Strategy for Advancing Preclinical Oncology Program in Mesothelioma
AUSTIN, Texas, Sept. 19, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4258494-1&amp;h=4023088732&amp;u=https%3A%2F%2Fwww.genprex.com%2F&amp;a=Genprex%2C+Inc.">Genprex, Inc.</a> ("Genprex" or the "Company") (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Mesothelioma Clinical Advisory Board to support the Company's preclinical mesothelioma oncology program. The Board is comprised of four world-renown researchers from major research institutions specializing in the treatment of mesothelioma.

Penny Stocks

GNPX

Genprex Announces Formation Of Mesothelioma Clinical Advisory Board  To Provide Strategy For Advancing Preclinical Oncology Program In Mesothelioma

Green Impact Partners reports Q3 results

Green Impact Partners finalizes tax credits for GreenGas Colorado sale

Green Impact Partners&nbsp; reports FY results

GIPIF

Press Releases

Green Impact Partners Finalizes Its Carbon Credit Pathways for the Future Energy Park

Green Impact Partners Reports Second Quarter 2024 Results and Key Highlights

TSXV:GIP

Green Impact Partners

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Green Impact Partners

News

Latest news for Green Impact Partners (OTC:GIPIF) Stock